Key Segmentation
By Product Type
-
Equipment
-
Accessories
By Equipment Type
-
Multipurpose Centrifuges
-
Microcentrifuges
-
Ultracentrifuges
-
Floor-Standing Centrifuges
By Intended Use
-
Clinical
-
Pre-Clinical Research
By Application
-
Diagnostics
-
Drug Discovery
-
Genomics and Proteomics
-
Blood Banking
By End User
-
Hospitals and Diagnostic Laboratories
-
Biotech and Pharma Companies
-
Academic and Research Institutes
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Thermo Fisher Scientific Inc., Danaher Corporation, Eppendorf SE, Andreas Hettich GmbH & Co. KG, and Sartorius AG, among other laboratory equipment manufacturers.
Continued development of natural refrigerant, energy-efficient cooling technology and continued expansion of single-use, closed-system centrifuge technology represent the primary opportunities.
Growth is primarily driven by increased research and development investment, combined with rising prevalence of infectious and chronic diseases driving higher sample testing volumes.
By Product Type, Equipment dominated the market with a 76.47% share in 2025, reflecting its role as the primary capital purchase for laboratory sample processing capability.
North America dominated the market with a 36.48% share in 2025, supported by advanced healthcare infrastructure and extensive research laboratory networks.
